We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 829

Washington Healthcare Update - Apr 16, 2018
  • McGuireWoods LLP
  • USA
  • April 16 2018

On April 11, Speaker of the House Paul Ryan announced he would not run for re-election to Congress. Already some in the House are suggesting Ryan


Federal Right To Try Legislation - Is It Any Better? - 2018 Edition
  • Reed Smith LLP
  • USA
  • March 23 2018

A little more than six months ago, we reviewed then-pending federal right-to-try legislation. Since then it’s become a shiny object, capable of


More Legislation To Watch
  • Reed Smith LLP
  • USA
  • January 29 2018

Like a lot of large firms, Reed Smith has a number of blogs. We don't mention them much because, DDL has product liability pretty well covered, and


The State AG Report Weekly Update December 14, 2017
  • Cozen O'Connor
  • USA
  • December 14 2017

Republican state Representative Todd Atwater has declared his candidacy for South Carolina AG in 201


Washington Healthcare Update - Oct 30, 2017
  • McGuireWoods LLP
  • USA
  • October 30 2017

Rep. Elijah Cummings (D-MD) and Sen. Bernie Sanders (I-VT) introduced legislation on Oct. 25 to let the government negotiate drug prices in Medicare


Washington Healthcare Update - Aug 7, 2017
  • McGuireWoods LLP
  • USA
  • August 7 2017

On July 31 the House Problem Solvers Caucus, a group comprising an even number of Democrats and Republicans, released a plan to fix the ACA. The plan


Washington Healthcare Update - Jul 17, 2017
  • McGuireWoods LLP
  • USA
  • July 17 2017

Earlier this week, House Energy & Commerce Oversight Subcommittee announced a hearing date has been set to discuss the 340B Drug Discount Program on


340B Update: Draft Executive Order Could Mean Changes to the 340B Program
  • K&L Gates
  • USA
  • July 13 2017

An early draft of the Trump administration’s proposed executive order (“EO”) on drug pricing issues could result in significant changes to the 340B


User Fee Reauthorization Picks Up Steam
  • Cooley LLP
  • USA
  • July 11 2017

In preparation for a vote this week, the House of Representatives Committee on Energy and Commerce yesterday released a new draft of the user fee


Washington Healthcare Update - Jul 3, 2017
  • McGuireWoods LLP
  • USA
  • July 3 2017

The House Appropriations Subcommittee for Agriculture, Rural Development, Food and Drug Administration (FDA), and Related Agencies released their